In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
1839 News Items found
(From left) David Scheinberg, Andrew Zelenetz, and Joseph Jurcic are using monoclonal antibodies to improve the treatment of patients with leukemia and lymphoma.
Monoclonal Antibody Drugs for Cancer Treatment

Therapies designed to target cancer while sparing healthy tissue show benefit, but have not yet reached full potential.
Research Provides Information About How Cancer Metastasis Occurs

Investigators at Memorial Sloan Kettering Cancer Center have found new clues about how metastatic cancer can form long after a primary tumor has been removed.
Starr Cancer Consortium Retreat Promotes Collaboration Among Grant Awardees

Memorial Sloan Kettering researchers gathered with scientists from four other institutions at Cold Spring Harbor Laboratory on Long Island in September to present and discuss projects funded by the Starr Cancer Consortium.
Alan Houghton with Pathologist Kay Park, Chair of the Junior Faculty Council
Alan Houghton Receives Mentorship Award

Memorial Sloan Kettering's Junior Faculty Council presented its 2008 Award for Excellence in Mentoring to Alan N. Houghton, Vice Chair for Academic Affairs in the Department of Medicine and incumbent of the Virginia and Daniel K. Ludwig Clinical Chair.
Michael Glickman
An Interview with Michael Glickman

Physician-scientist Michael S. Glickman specializes in the treatment and study of infectious diseases.
(Left to right) Medical oncologist Mark Robson, gynecologist Noah Kauff, medical oncologist Zsofia Stadler, and Clinical Genetics Service Chief Kenneth Offit are applying genetic insights to improve the care of cancer patients.
Genetic Information Becomes a Vital Part of Clinical Practice

At Memorial Sloan Kettering, as the genetics revolution continues to flourish, discoveries made in the laboratory are increasingly producing real-world benefits for cancer patients.
Memorial Sloan Kettering Team Develops Tool to Advance Stem Cell Research

Investigators at Memorial Sloan Kettering have developed a new tool that could help them advance the understanding of human embryonic stem cells.
Scott N. Keeney
Scott Keeney Selected as a Howard Hughes Medical Institute Investigator

Scott N. Keeney, a member of the Molecular Biology Program within the Sloan Kettering Institute, was one of 56 researchers to be appointed a Howard Hughes Medical Institute (HHMI) investigator in 2008.
Thomas Kelly Named to Advisory Committee at National Institutes of Health

Sloan Kettering Institute Director Thomas J. Kelly has been named a member of the Advisory Committee to the Director (ACD) at the National Institutes of Health.
Pictured: James Allison
James Allison Elected to the Institute of Medicine

James P. Allison, Chair of the Immunology Program in the Sloan Kettering Institute, has been elected a member of the Institute of Medicine.